WHO recommendations for early antimicrobial treatment of child pneumonia were effective in reducing child mortality, but the last major revision was more than 10 years ago. The emergence of antimicrobial resistance, new pneumonia pathogens, as well as new drugs prompted the WHO to gather an international group to review the literature on infant pneumonia, and develop science-based recommendations for empirical therapy is easy to pneumonia in children managed the first level of health providers. Treatment should be directed to bacterial causes often lead to severe illness, including
Streptoccocus pneumonia and Haemophilus influenzae. The best first-line drug is amoxicillin twice a day for 3-5 days, though-trimoksazola may be an alternative in some situations. Poor treatment should be defined in a child who develops symptoms require immediate treatment or with no decrease in respiratory rate after 48-72 h of therapy. If the crashes, and no instructions on immediate referral exists, possible explanations for failure to systematically determine, including the failure of therapy and alternative strattera dosage diagnoses. If the cancellation of the first line drug remains a possible explanation, suitable second-line agents include high doses of amoxicillin-clavulanic acid with or without available macrolides for children over 3 years. .
No comments:
Post a Comment